Work

Identification of An Active, Well-Tolerated Dose of Pralatrexate In Patients with Relapsed or Refractory Cutaneous T-Cell Lymphoma (CTCL): Final Results of a Multicenter Dose-Finding Study.

Year: 2010

Type: article

Source: Blood

DOI: 10.1182/blood.v116.21.2800.2800

Authors: Steven M Horwitz, Youn H. Kim, Francine M Foss, Jasmine M. Zain, Patricia Myskowski, Mary Jo Lechowicz, David C. Fisher, Andrei Shustov, Nancy L. Bartlett, Maria L Delioukina, Tony Koutsoukos, Steven M. Fruchtman, Owen A. O'Connor, Madeleine Duvic

Institutions: Memorial Sloan Kettering Cancer Center, Stanford Medicine, Stanford University, Yale Cancer Center, NYU Langone Health, New York University, Emory University, Winship Cancer Institute, Dana-Farber Cancer Institute, University of Washington, Washington University in St. Louis, City Of Hope National Medical Center, The Princeton Festival, The University of Texas MD Anderson Cancer Center

Language: English

Topic: Cutaneous lymphoproliferative disorders research

Subfield: Dermatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2582397577

FWCI: 3.097

Cites:

Cited by: 20

Related to: 10